ロード中...
The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases
Osteocytes are the most abundant (~95%) cells in bone with the longest half-life (~25 years) in humans. In the past osteocytes have been regarded as vestigial cells in bone, since they are buried inside the tough bone matrix. However, during the last 30 years it has become clear that osteocytes are...
保存先:
| 出版年: | Front Endocrinol (Lausanne) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7360678/ https://ncbi.nlm.nih.gov/pubmed/32733380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00405 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|